Charlotte's Web Holdings (CWBHF) Cash from Investing Activities (2021 - 2026)
Charlotte's Web Holdings' (CWBHF) quarterly Cash from Investing Activities came in at -$17000.0 in Q1 2026, up 96.55% year-on-year from -$8649.1 in Q1 2025, and down 114.66% on a QoQ basis from $116000.0 in Q4 2025.
Charlotte's Web Holdings (CWBHF) Cash from Investing Activities (2021 - 2026) Analysis & Trends
Charlotte's Web Holdings (CWBHF) has 6 years of Cash from Investing Activities data on file, last reported at -$17000.0 in Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 96.55% year-over-year to -$17000.0 in Q1 2026; TTM through Mar 2026 was $64000.0, a 102.84% increase from a year earlier, with the FY2025 full-year figure at -$412000.0, up 89.15% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$17000.0, down from $116000.0 in the prior quarter.
- Over the last five years, Cash from Investing Activities for CWBHF reached as high as $452000.0 in Q4 2022 and fell as low as -$2.7 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$431529.4 across 5 years, with a median of -$111000.0 in 2023.
- Across the five-year window, Cash from Investing Activities surged 164.66% in 2022 and sank 4982.5% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at $452000.0 in 2022, then slumped by 234.96% to -$610000.0 in 2023, then surged by 67.54% to -$198000.0 in 2024, then jumped by 158.59% to $116000.0 in 2025, then plunged by 114.66% to -$17000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$17000.0 in Q1 2026, $116000.0 in Q4 2025, and $11000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 229.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -87.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -369.95 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 743.70 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 277.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -506.20 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -60.00 Mn |
| 10 | Charlotte's Web Holdings | 41.51 Mn | 36.32 Mn | 5.20 Mn | -17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Sep 30, 2025 | 11,000.00 |
| Jun 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -46,000.00 |
| Mar 31, 2025 | -493,000.00 |
| Mar 31, 2025 | -493,000.00 |
| Dec 31, 2024 | -198,000.00 |
| Dec 31, 2024 | -198,000.00 |
| Sep 30, 2024 | -310,000.00 |
| Sep 30, 2024 | -310,000.00 |
| Jun 30, 2024 | -1.26 Mn |
| Jun 30, 2024 | -1.26 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Mar 31, 2024 | -2.03 Mn |
| Dec 31, 2023 | -610,000.00 |
| Dec 31, 2023 | -610,000.00 |